A detailed history of Mystic Asset Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mystic Asset Management, Inc. holds 15,553 shares of ABBV stock, worth $2.79 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
15,553
Previous 15,757 1.29%
Holding current value
$2.79 Million
Previous $2.7 Million 13.66%
% of portfolio
1.18%
Previous 1.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $33,423 - $40,663
-204 Reduced 1.29%
15,553 $3.07 Million
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $16,872 - $19,702
109 Added 0.7%
15,757 $2.7 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $88,060 - $100,337
551 Added 3.65%
15,648 $2.85 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $98,934 - $111,423
-719 Reduced 4.55%
15,097 $2.34 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $10,019 - $11,598
75 Added 0.48%
15,816 $2.36 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $52,871 - $65,795
-399 Reduced 2.47%
15,741 $2.12 Million
Q1 2023

Apr 21, 2023

SELL
$144.61 - $166.54 $2,892 - $3,330
-20 Reduced 0.12%
16,140 $2.57 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $3,457 - $4,146
25 Added 0.15%
16,160 $2.61 Million
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $13,421 - $15,393
100 Added 0.62%
16,135 $2.17 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $98,398 - $125,096
715 Added 4.67%
16,035 $2.46 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $65,990 - $81,875
-500 Reduced 3.16%
15,320 $2.48 Million
Q4 2021

Feb 23, 2022

BUY
$107.43 - $135.93 $1.7 Million - $2.15 Million
15,820 New
15,820 $2.14 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mystic Asset Management, Inc. Portfolio

Follow Mystic Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mystic Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mystic Asset Management, Inc. with notifications on news.